Need Help?

RNA sequencing of multiple tumor biopsies and patient-derived spheroids from five colorectal cancer patients (BAM files)

Whole transcriptome, strand-specific RNA-seq libraries were prepared from total RNA purified using RNeasy mini kit (Qiagen) using Ribo-Zero technology (Epicentre, an Illumina company) for depletion of rRNA followed by library preparation using ScriptSeq ScriptSeq RNA-Seq Library preparation Kit from Illumina. The paired raw sequence reads were processed using TopHat2 and mapped to the humane reference genome HG19.

Request Access

MOMA DAC Access Policy

This document specifies the policy for granting access to the European Genome-phenome Archive (EGA) secure Web based tools for managing data access permissions to the data stored in the EGA database. Access is granted to those Data Access Committee members named in this document by Paul Flicek, head of Genes, Genomes and Variation.Conditions of access:The account holder will abide by all current and future policies of the EBI for computer use as well as computer use policies of the European Molecular Biology Laboratory (EMBL), of which the EBI is a part. All EGA specific policies and standard operating procedures (SOPs) must also be followed. All applicable policies will be provided to the authorized users. Method of access:The EBI will create a personal account for the authorized person. The account username and password together with a RSA key provide access to the secure EGA infrastructure. A separate document with detailed guidelines on how to access and use these tools is provided to each account holder. The EGA help-desk provides training when needed.Review:All individuals will access to the EGA user authorization tools will be reviewed annually by Paul Flicek. Any staff changes affecting the authorized person must be provided immediately to Paul Flicek ( Data Access Committee user:Henrik Hornshøj ( and Søren Vang ( of Molecular Medicine (MOMA), Aarhus University Hospital, Brendstrupgårdsvej 100, 8200 Aarhus N, Denmark

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001002684 Other
ID File Type Size Located in
EGAF00001794412 bam 3.8 GB
EGAF00001794413 bam 796.1 MB
EGAF00001794414 bam 4.5 GB
EGAF00001794415 bam 568.9 MB
EGAF00001794416 bam 3.6 GB
EGAF00001794417 bam 762.6 MB
EGAF00001794418 bam 10.1 GB
EGAF00001794419 bam 1.3 GB
EGAF00001794420 bam 3.3 GB
EGAF00001794421 bam 527.3 MB
EGAF00001794422 bam 4.1 GB
EGAF00001794423 bam 972.1 MB
EGAF00001794424 bam 3.9 GB
EGAF00001794425 bam 3.4 GB
EGAF00001794426 bam 4.6 GB
EGAF00001794427 bam 763.6 MB
EGAF00001794428 bam 3.1 GB
EGAF00001794429 bam 656.4 MB
EGAF00001794430 bam 6.2 GB
EGAF00001794431 bam 781.3 MB
EGAF00001794432 bam 2.7 GB
EGAF00001794433 bam 432.1 MB
EGAF00001794434 bam 11.3 GB
EGAF00001794435 bam 1.4 GB
EGAF00001794436 bam 4.5 GB
EGAF00001794437 bam 684.4 MB
EGAF00001794438 bam 4.4 GB
EGAF00001794439 bam 1.0 GB
EGAF00001794440 bam 3.1 GB
EGAF00001794441 bam 531.7 MB
EGAF00001794442 bam 4.1 GB
EGAF00001794443 bam 739.1 MB
32 Files (92.7 GB)